Literature DB >> 20810278

Resolution of racemic sulfoxides with high productivity and enantioselectivity by a Rhodococcus sp. strain as an alternative to biooxidation of prochiral sulfides for efficient production of enantiopure sulfoxides.

Ai-Tao Li1, Hui-Lei Yu, Jiang Pan, Jian-Dong Zhang, Jian-He Xu, Guo-Qiang Lin.   

Abstract

Whole cells of Rhodococcus sp. ECU0066 were used a catalyst for resolution of racemic sulfoxides, as an alternative to asymmetric oxidation of sulfides for efficient production of enantiopure sulfoxides. Racemic sulfoxides were excellent substrates for biotransformation because of their lower biotoxicity compared to sulfides. Determination of apparent kinetic parameters indicated that phenyl methyl sulfide (PMS), but not racemic phenyl methyl sulfoxide (rac-PMSO) caused substrate inhibition. (S)-PMSO was formed at a higher concentration and good enantiomeric excess (37.8 mM and 93.7% ee(S)) in a fed-batch reaction, than by an asymmetric oxidation of PMS (10 mM and 80% eeP (S)). The bacterium also displayed fairly good activity (yields, 22.7-43.2%; within 1-8 h) and enantioselectivity (ee(S)>99.0%) towards para-substituted (methyl and chloro) phenyl methyl sulfoxides and ethyl phenyl sulfoxide, indicating it could be a promising agent for synthetic applications. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810278     DOI: 10.1016/j.biortech.2010.08.025

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  2 in total

1.  A Baeyer-Villiger monooxygenase from Cupriavidus basilensis catalyzes asymmetric synthesis of (R)-lansoprazole and other pharmaco-sulfoxides.

Authors:  Feng Liu; Chao Shou; Qiang Geng; Chen Zhao; Jianhe Xu; Huilei Yu
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-29       Impact factor: 4.813

2.  Enantioselective sulfoxidation using Streptomyces glaucescens GLA.0.

Authors:  Sara Salama; Tarek Dishisha; Mohamed H Habib; Ahmed Z Abdelazem; Walid Bakeer; Mahmoud Abdel-Latif; Yasser Gaber
Journal:  RSC Adv       Date:  2020-09-01       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.